Abstract:Obesity remains a significant global health challenge, with bariatric surgery remaining as one of the most effective treatments for severe obesity and its related comorbidities. This review highlights the multifaceted impact of bariatric surgery beyond mere physical restriction or nutrient malabsorption, underscoring the importance of the gut microbiome and neurohormonal signals in mediating the profound effects on weight loss and behavior modification. The various bariatric surgery procedures, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), act through distinct mechanisms to alter the gut microbiome, subsequently impacting metabolic health, energy balance, and food reward behaviors. Emerging evidence has shown that bariatric surgery induces profound changes in the composition of the gut microbiome, notably altering the Firmicutes/Bacteroidetes ratio and enhancing populations of beneficial bacteria such as Akkermansia. These microbiota shifts have far-reaching effects beyond gut health, influencing dopamine-mediated reward pathways in the brain and modulating the secretion and action of key gut hormones including ghrelin, leptin, GLP-1, PYY, and CCK. The resultant changes in dopamine signaling and hormone levels contribute to reduced hedonic eating, enhanced satiety, and improved metabolic outcomes. Further, post-bariatric surgical effects on satiation targets are in part mediated by metabolic byproducts of gut microbiota like short-chain fatty acids (SCFAs) and bile acids, which play a pivotal role in modulating metabolism and energy expenditure and reducing obesity-associated inflammation, as well as influencing food reward pathways, potentially contributing to the regulation of body weight and reduction in hedonic eating behaviors. Overall, a better understanding of these mechanisms opens the door to developing non-surgical interventions that replicate the beneficial effects of bariatric surgery on the gut microbiome, dopamine signaling, and gut hormone regulation, offering new avenues for obesity treatment.

Gut motility and hormone changes after bariatric procedures

Small intestine-targeted endoscopic bariatrics: current status and future perspectives.

Influence of Bariatric Surgery on Gut Microbiota Composition and Its Implication on Brain and Peripheral Targets

Microbiota dynamics preceding bariatric surgery as obesity treatment: a comprehensive review

The Effects of Bariatric Procedures on Bowel Habit

Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery

Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms

Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery

Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery

Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity

Physiological Appetite Regulation and Bariatric Surgery

Impact of bariatric surgery on gut microbiota composition in obese patients compared to healthy controls

Gut microbiota in bariatric surgery

Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels

Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review

Small Bowel Therapies for Metabolic Disease and Obesity

EP.WE.824Effect of bariatric surgery on gut permeability in humans: a systematic review

Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass

Characterization of the plasma metabolome and lipidome in response to sleeve gastrectomy and gastric bypass surgeries reveals molecular patterns of surgical weight loss

Open to Laparoscopic to Robotic

Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future